Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
The classification of Dry Eye Drugs includes Artificial Tears, Anti-inflammatory drugs and other, and the proportion of Artificial Tears in 2017 is about 89%.
The global Dry Eye Drugs market was valued at US$ 6782.8 million in 2019 and is expected to reach US$ 15120 million by the end of 2026, growing at a CAGR of 12.0% during 2021-2026.
This report focuses on Dry Eye Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Dry Eye Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Dry Eye Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other
Segment by Application
Hospital
Drug Stores
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Allergan
Novartis AG
Bausch Health
Santen Pharma
Takeda
Johnson & Johnson
United Laboratories
Senju Pharmaceutical
Jianfeng Group
Eusan GMBH
The classification of Dry Eye Drugs includes Artificial Tears, Anti-inflammatory drugs and other, and the proportion of Artificial Tears in 2017 is about 89%.
The global Dry Eye Drugs market was valued at US$ 6782.8 million in 2019 and is expected to reach US$ 15120 million by the end of 2026, growing at a CAGR of 12.0% during 2021-2026.
This report focuses on Dry Eye Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Dry Eye Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Dry Eye Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other
Segment by Application
Hospital
Drug Stores
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Allergan
Novartis AG
Bausch Health
Santen Pharma
Takeda
Johnson & Johnson
United Laboratories
Senju Pharmaceutical
Jianfeng Group
Eusan GMBH
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
